+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Aptamers Market Size, Share and Growth Outlook, 2026: Analysis By Type (Nucleic Acid Aptamers , Peptide Aptamers), By Technology (SELEX , In-Silico Aptamer Discovery , X-Aptamer Technology), By Application (Diagnostics , Therapeutics Development , Research and Development ), By End User (Pharmaceutical and Biotechnology Companies, Academic and Government Research Institutes, Contract Research Organizations , Diagnostic Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Aptamers Market size is forecast to increase from $508.43 Million in 2026 to $2769.36 Million in 2034 at a CAGR of 23.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005697
Pages: 212 Pages

Appetite Stimulant Market Size, Share and Growth Outlook, 2026: Analysis By Pharmacological Class (Progestational & Hormonal Agents, Cannabinoids & CNS-Acting Agents, Corticosteroids, Anabolic & Metabolic Agents, Nutritional & Micronutrient Agents), By Type (Prescription Medications, Over-The-Counter , Natural), By Indication (Disease-Related Cachexia , Chronic Disease-Associated Malnutrition, Age-Related & General Anorexia, Pediatric Undernutrition), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Appetite Stimulant Market size is forecast to increase from $1.75 Billion in 2026 to $2.9 Billion in 2034 at a CAGR of 6.54% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005696
Pages: 216 Pages

Apheresis Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Apheresis Devices , Apheresis Consumables ), By Technology (Centrifugation, Membrane Filtration), By Procedure Type (Plasmapheresis, Photopheresis, Erythrocytapheresis, Leukapheresis, Plateletpheresis, LDL Apheresis), By Application (Neurological Disorders, Hematological Disorders, Renal Disorders, Autoimmune Disorders, Cardiovascular Disorders), By End User (Hospitals and Clinics, Blood Donation Centers, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Apheresis Devices Market size is forecast to increase from $3.93 Billion in 2026 to $8.06 Billion in 2034 at a CAGR of 9.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005695
Pages: 221 Pages

Aorto-iliac Occlusive Disease Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Device Type (Endovascular Devices , Surgical Devices ), By Stent Product Configuration (Balloon-Expandable Stents, Self-Expanding Stents, Covered Stent Grafts, Bifurcated Aortic Stent Grafts), By Procedure Type (Endovascular Procedures , Open Surgical Procedures , Hybrid Procedures), By End-User (Hospitals and Vascular Surgery Departments, Outpatient Facilities / Ambulatory Surgery Centers, Specialized Interventional Suites and Cath Labs) Companies, and Country Forecast, 2021 to 2034

Global Aorto-iliac Occlusive Disease Treatment Market size is forecast to increase from $2.84 Billion in 2026 to $4.33 Billion in 2034 at a CAGR of 5.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005694
Pages: 218 Pages

Aortic Valve Replacement Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Transcatheter Aortic Valve Replacement , Biological / Tissue Surgical Valves , Mechanical Surgical Valves, Sutureless / Rapid-Deployment Valves), By TAVR Frame Mechanism (Balloon-Expandable Systems, Self-Expandable Systems, Mechanically Expandable Systems), By Target Clinical Indication (Aortic Stenosis, Aortic Regurgitation / Insufficiency), By End-User (Hospitals and Tertiary Heart Centers, Cardiac Catheterization Laboratories , Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Aortic Valve Replacement Devices Market size is forecast to increase from $8.92 Billion in 2026 to $19.54 Billion in 2034 at a CAGR of 10.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005693
Pages: 219 Pages

Aortic Stent Grafts Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Abdominal Aortic Stent Grafts , Thoracic Aortic Stent Grafts ), By Fixation (Suprarenal Fixation Systems, Infrarenal Fixation Systems, Fenestrated and Branched Stent Grafts), By Material Type (Synthetic Fabrics , Metallic Scaffold Biomaterials , Allograft Materials), By End-User (Hospitals and Inpatient Cardiac Centers, Ambulatory Surgical Centers , Specialized Vascular Clinics) Companies, and Country Forecast, 2021 to 2034

Global Aortic Stent Grafts Market size is forecast to increase from $3.99 Billion in 2026 to $5.94 Billion in 2034 at a CAGR of 5.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005692
Pages: 211 Pages

Aortic Repair Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Endovascular Stent Grafts , Thoracic Endovascular Stent Grafts , Fenestrated and Branched Stent Grafts , Surgical Grafts , Hybrid Aortic Repair Devices), By Application (Abdominal Aortic Aneurysm , Thoracic Aortic Aneurysm , Aortic Dissection and Transection Repair), By End-User (Hospitals and Large Healthcare Systems, Ambulatory Surgical Centers , Specialty Cardiovascular Clinics) Companies, and Country Forecast, 2021 to 2034

Global Aortic Repair Devices Market size is forecast to increase from $3.27 Billion in 2026 to $5.06 Billion in 2034 at a CAGR of 5.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005691
Pages: 212 Pages

Aortic Aneurysm Market Size, Share and Growth Outlook, 2026: Analysis By Aneurysm Type (Abdominal Aortic Aneurysm , Thoracic Aortic Aneurysm , Thoracoabdominal Aortic Aneurysm ), By Treatment Modality (Endovascular Aneurysm Repair , Open Surgical Repair , Medication , Clinical Monitoring & Surveillance), By Product Component (Aortic Stent Grafts, Aortic Surgical Grafts, Aortic Repair Accessory Devices ), By End-User (Hospitals and Trauma Centers, Ambulatory Surgical Centers , Specialized Cardiac & Vascular Clinics) Companies, and Country Forecast, 2021 to 2034

Global Aortic Aneurysm Market size is forecast to increase from $6.33 Billion in 2026 to $17.07 Billion in 2034 at a CAGR of 13.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005690
Pages: 216 Pages

Antiviral Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Indication (Human Immunodeficiency Virus , Hepatitis , Coronavirus Infection , Influenza, Herpes Simplex Virus , Others), By Drug Type (Branded Antiviral Drugs, Generic Antiviral Drugs), By Route of Administration (Oral, Parenteral , Topical), By Patient Demographic (Adult, Geriatric, Pediatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Antiviral Drugs Market size is forecast to increase from $63.37 Billion in 2026 to $84.09 Billion in 2034 at a CAGR of 3.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005689
Pages: 213 Pages

Antivenom Market Size, Share and Growth Outlook, 2026: Analysis By Type (Polyvalent Antivenom, Monovalent Antivenom), By Source (Equine-Derived , Ovine-Derived , Recombinant DNA), By Product Type (Snake Antivenom, Scorpion Antivenom, Spider Antivenom, Tick and Marine Animal Antivenom), By Mode of Action (Neurotoxic, Hemotoxic, Cytotoxic, Cardiotoxic), By End User (Hospitals & Clinics, Trauma & Emergency Centers, Military & Special-Purpose Units, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Antivenom Market size is forecast to increase from $1.41 Million in 2026 to $2.71 Million in 2034 at a CAGR of 8.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005688
Pages: 219 Pages